About Us
- About Us
Products
- Products
  - Our Product Pricing
R&D
- R&D
Sustainability
- Sustainability
Investor Relations
Contact Us
News & Media
Join Us
- Join Us

-->

Ocera

In This Section

Executive Committee
Board of Directors
Specialty Generics
Core Strengths
Our Story
Partnering
Patient Stories
155th Anniversary

Ocera Therapeutics is now a part of Mallinckrodt

To learn more about our development product OCR-002 (l-ornithine phenylacetate), visit our pipeline page.

Ocera

Careers at Mallinckrodt
Community Outreach
Investor Relations

Building On Our Heritage

More than 150 years of quality, integrity and service.

Learn More

Our Culture

From philanthropic efforts to advocacy initiatives, we are living our values throughout our communities.

Learn How

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2021 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc,(in examination under Part 10 of the Companies Act 2014), which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.

UnitedHealthcare creates and publishes the Machine-Readable Files on behalf of Mallinckrodt. To link to the Machine-Readable Files, please click on the URL provided: transparency-in-coverage.uhc.com.

Resources For:

Career Seekers
Investors
Suppliers

About Mallinckrodt:

About Us
Home
Investor Relations
News & Media
Products
Research
Sustainability

Other Links:

Safety Data Sheets
Calif. Supply Chain Disclosure
Contact Us
Patents
Privacy Policy
Terms of Use
UK Modern Slavery Act Disclosure
2023 Therakos UK Carbon Reduction Plan
UHC Transparency in Coverage
C-TPAT Statement of Support
Vulnerability Disclosure Policy

Privacy Choices